Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis
Sign Up to like & getrecommendations! Published in 2017 at "Acta Neuropathologica"
DOI: 10.1007/s00401-017-1785-8
Abstract: Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease with no effective treatments. Numerous RNA-binding proteins (RBPs) have been shown to be altered in ALS, with mutations in 11 RBPs causing familial forms of the… read more here.
Keywords: disease; watson; amyotrophic lateral; rbps ... See more keywords
Identification of glomerulosclerosis using IBM Watson and shallow neural networks
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Nephrology"
DOI: 10.1007/s40620-021-01200-0
Abstract: Background Advanced stages of different renal diseases feature glomerular sclerosis at a histological level which is observed by light microscopy on tissue samples obtained by performing a kidney biopsy. Computer-aided diagnosis (CAD) systems leverage the potential… read more here.
Keywords: system; glomerulosclerosis using; ibm watson; sclerotic glomeruli ... See more keywords
IBM Watson Evidence Service (WES): A system for retrieval, summation and insight generation of relevant clinical evidence for personalized oncology.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e18588
Abstract: e18588Background: There were ~49,300 clinical research publications in oncology in the last 10 years. Oncologists do not have the time to read them all. AI and computationally assisted systems may ... read more here.
Keywords: watson evidence; oncology ibm; evidence; evidence service ... See more keywords
"A Tool, Not a Crutch": Patient Perspectives About IBM Watson for Oncology Trained by Memorial Sloan Kettering.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of oncology practice"
DOI: 10.1200/jop.18.00417
Abstract: PURPOSE IBM Watson for Oncology trained by Memorial Sloan Kettering (WFO) is a clinical decision support tool designed to assist physicians in choosing therapies for patients with cancer. Although substantial technical and clinical expertise has… read more here.
Keywords: watson oncology; wfo; oncology trained; ibm watson ... See more keywords